France· FR:64716254
BUDESONIDE ZENTIVA 1 mg/2 ml, suspension pour inhalation par nébuliseur en récipient unidose
A medicinal product containing budésonide, registered in France by ZENTIVA FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BUDÉSONIDE
- Manufacturer
- ZENTIVA FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093020234020 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 2 ml en sachets polytéréphtalate (PET) aluminium polyéthylène de (4x5)EUR 24.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Budésonide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandBDS NAurovitas Pharma Polska Sp. z o.o.
- ItalyAIRCORTITALCHIMICI S.P.A.
- BelgiumBudesonid Sandoz 0.5 mg/mlSandoz
- United StatesBudesonideSun Pharmaceutical Industries, Inc.
- SwedenBudesonid Zentiva 0,5 mg/ml Suspension för nebulisatorZentiva k.s.
- FinlandBudesonide StadaSTADA Arzneimittel AG
- IrelandBudesonide Azure 1 mg/2 ml Nebuliser SuspensionAzure Pharmaceuticals Ltd.
- NetherlandsBudesonide 1000 microgram/2ml, Focus Care, vernevelsuspensieFocus Care Pharmaceuticals B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Budenofalk, Budo-San
- Belgium · Budenofalk, Budesonid Sandoz
- Bulgaria · Airbudenid, Буденофалк
- Cyprus · Axelovert, Biosonide
- Czechia · Budenofalk, Budenofalk Uno
- Germany · Aquacort, Budapp Nasal
- Denmark · Benarhin, Budenofalk
- Estonia · Budesonid Sandoz, Budesonide
- Spain · Budena, Budesonida
- Finland · Budenofalk, Budesonid Easyhaler Orion
- United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
- Greece · Aurid, Axelovert
- Croatia · Budelin Novolizer, Budosan
- Hungary · Budenofalk, Budesonid Easyhaler
- Ireland · Budenofalk, Budesonide Azure
- Iceland · Budesonide Stada, Cortiment
- Italy · Aircort, Bidien
- Liechtenstein · Jorveza, Kinpeygo
- Lithuania · Budenofalk, Budesonide Ferring
- Luxembourg · Budenofalk, Budesonide Eg
- Latvia · Budenofalk, Budesonid Sandoz
- Malta · Budesonida Aldo-Unión, Budesonide Azure
- Netherlands · Budenofalk, Budenofalk Schuim
- Norway · Budenofalk, Budesonid Medical Valley
- Poland · Bds N, Benodil
- Portugal · Aeromax, Budenofalk
- Romania · Budenofalk, Budenofalk Uno
- Sweden · Budaxiro, Budenofalk
- Slovenia · Budenofalk, Budesonid Easyhaler Orion
- Slovakia · Budelin Novolizer, Budenofalk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0661521d-b7d3-447d-ba76-26623fe64355 GET /v1/drugs/0661521d-b7d3-447d-ba76-26623fe64355?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64716254",
"date_amm": "2020-03-02",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BUDÉSONIDE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "suspension pour inhalation par nébuliseur",
"voies_administration": "inhalée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about budésonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.